Bio-Rad Laboratories (BIO) Operating Leases (2019 - 2025)
Historic Operating Leases for Bio-Rad Laboratories (BIO) over the last 7 years, with Q4 2025 value amounting to $181.8 million.
- Bio-Rad Laboratories' Operating Leases rose 502.6% to $181.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $181.8 million, marking a year-over-year increase of 502.6%. This contributed to the annual value of $181.8 million for FY2025, which is 502.6% up from last year.
- As of Q4 2025, Bio-Rad Laboratories' Operating Leases stood at $181.8 million, which was up 502.6% from $192.6 million recorded in Q3 2025.
- Bio-Rad Laboratories' 5-year Operating Leases high stood at $212.9 million for Q3 2021, and its period low was $167.6 million during Q1 2025.
- For the 5-year period, Bio-Rad Laboratories' Operating Leases averaged around $194.0 million, with its median value being $193.4 million (2022).
- As far as peak fluctuations go, Bio-Rad Laboratories' Operating Leases skyrocketed by 1378.93% in 2023, and later plummeted by 1611.61% in 2025.
- Quarter analysis of 5 years shows Bio-Rad Laboratories' Operating Leases stood at $212.3 million in 2021, then dropped by 10.55% to $189.9 million in 2022, then rose by 8.43% to $205.9 million in 2023, then fell by 15.93% to $173.1 million in 2024, then rose by 5.03% to $181.8 million in 2025.
- Its Operating Leases stands at $181.8 million for Q4 2025, versus $192.6 million for Q3 2025 and $204.1 million for Q2 2025.